Answers are grounded in this paper and cite their sources.
Randomized controlled trial shows high-power holmium: YAG lasers enhance operative efficiency in renal procedures, indicating improved outcomes.
To compare operative efficiency and perioperative outcomes between low-power (LP) and high-power (HP) holmium: yttrium aluminum–garnet (Ho: YAG) laser strategies in suction-assisted mini–percutaneous nephrolithotomy (mini-PCNL), we conducted a prospective randomized controlled trial including 100 adult patients with renal calculi randomized 1:1 to LP ( n = 50) or HP ( n = 50) settings. All procedures were performed using suction-assisted mini-PCNL. The primary outcome was total operative time, with secondary outcomes including laser activation time, total laser energy, energy density, ablation speed, stone-free rate (SFR) at 6 weeks, and complications. Baseline characteristics were comparable between groups. The HP group demonstrated significantly shorter operative time (90.7 ± 18.7 vs. 112.1 ± 40.3 min; P = 0.001) and laser activation time (1893 ± 499 vs. 2548 ± 1001 s; P = 0.001). Although total energy delivery was higher in the HP group (37.6 vs. 25.1 kJ; P = 0.001), ablation speed was significantly greater (1.6 vs. 1.2 mm³/s; P = 0.002), while the LP group showed greater energy efficiency (10.9 vs. 16.4 J/mm³; P = 0.002). Six-week SFR (86.0% vs. 88.0%; P = 0.766), complication rates, and hospital stay were comparable. Within a suction-assisted mini-PCNL setting, HP Ho: YAG laser strategies were associated with improved operative efficiency, primarily reflected by shorter operative and lasing times, at the expense of lower energy efficiency, without differences in short-term clinical outcomes. These findings should be interpreted as reflecting differences in clinically applied laser strategies rather than isolated laser power effects.
No takes yet. Share an insight, caveat, or question.
Sirajarus et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: